Not Yet Recruiting
GMMG-HD11/DSMM XXI/64007957MMY3010
NCT07671287
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Clinical trial condition
Paraproteinemias
Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.
3,004 public trials
571 recruiting studies
Paraproteinemias trial results
Not Yet Recruiting
Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention
NCT07649681
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +42 more
- Locations
-
- Universitätsklinikum Augsburg Augsburg, Bavaria, Germany
- Universitätsklinikum Erlangen Erlangen, Bavaria, Germany
- LMU Klinikum Krebszentrum - CCC MünchenLMU - Comprehensive Cancer Center München, Bavaria, Germany
- Klinikum der Technischen Universität München (TUM Klinikum) München, Bavaria, Germany
Not Yet Recruiting
Delayed Toxicities Post-CAR-T
NCT07665307
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
- Locations
-
- UCSF Medical Center San Francisco, California, United States
- Mount Sinai New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Not Yet Recruiting
Study of Alternative and Approved Dosing Regimens of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Relapsed/Refractory Multiple Myeloma
NCT07614360
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Not Yet Recruiting
ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma
NCT07247097
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Not Yet Recruiting
GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders
NCT07660939
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors
NCT07592481
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
- Locations
-
Not specified
Not Yet Recruiting
PET-Enabled Dual-Energy CT in Multiple Myeloma
NCT07646873
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- UC Davis EXPLORER Molecular Imaging Center Sacramento, California, United States
Not Yet Recruiting
A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma
NCT07612787
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Centre Hospitalier Universitaire Amiens, France
- Centre Hospitalier Universitaire Angers, France
- Centre Hospitalier Universitaire Annecy, France
- Centre Hospitalier D'Argenteuil Argenteuil, France
Not Yet Recruiting
CM336-SOC for Dynamically High-Risk Multiple Myeloma Study
NCT07648459
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified